| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |